As of Jul 31, 2026, CME's PEG ratio of 1.52 reflects its valuation relative to its growth. This value reflects a P/E ratio of 22.54 measured against EPS growth of 14.8%. When compared to the trailing four-quarter average of 1.83, CME's PEG ratio shows a 17% decrease.
CME Group Inc - Class A's ten years historical PEG ratio has an average of 3.03. Compared to historical data, CME's 1.52 PE to growth ratio represents a decline of 50%. CME reached its maximum PEG ratio of 15.13 during the Dec 2022 quarter over the past ten years. The Sep 2018 quarter had the bottom reading at 0.06, indicating the most optimal growth-adjusted valuation.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 1.59 | 24.43 | 15.4% |
| 2024 | 2.61 | 23.97 | 9.2% |
| 2023 | 1.21 | 23.74 | 19.7% |
| 2022 | 15.13 | 22.69 | 1.5% |
| 2021 | 1.3 | 31.3 | 24.1% |
| 2020 | N/A | 30.96 | -0.8% |
| 2019 | 9.67 | 33.85 | 3.5% |
| 2018 | N/A | 32.83 | -52.3% |
| 2017 | 0.07 | 12.17 | 163.7% |
| 2016 | 1.12 | 25.35 | 22.6% |
| 2015 | 2.42 | 24.42 | 10.1% |
| 2014 | 1.8 | 26.31 | 14.6% |
| 2013 | 3.14 | 26.69 | 8.5% |
| 2012 | N/A | 18.7 | -50.3% |
| 2011 | 0.1 | 8.94 | 89.9% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Jun 2026 | 1.26 | 18.59 | 14.8% |
| Mar 2026 | 1.36 | 25.03 | 18.4% |
| Dec 2025 | 1.59 | 24.43 | 15.4% |
| Sep 2025 | 3.11 | 26.16 | 8.4% |
| Jun 2025 | 1.9 | 26.63 | 14% |
| Mar 2025 | 1.99 | 26.61 | 13.4% |
| Dec 2024 | 2.61 | 23.97 | 9.2% |
| Sep 2024 | 1.7 | 23.15 | 13.6% |
| Jun 2024 | 2.02 | 21.65 | 10.7% |
| Mar 2024 | 2.13 | 24.49 | 11.5% |
| Dec 2023 | 1.21 | 23.74 | 19.7% |
| Sep 2023 | 1.67 | 23.86 | 14.3% |
| Jun 2023 | 13.29 | 22.6 | 1.7% |
| Mar 2023 | 8.38 | 24.3 | 2.9% |
| Dec 2022 | 15.13 | 22.69 | 1.5% |
When comparing to historical values, CME's PEG ratio is below the 3, 5 and 10-year averages.
With a PEG of 1.52, CME is above the Financial Services sector, the industry and its peers average. Compared to its Financial Services sector average of 0.48, CME Group Inc - Class A's PEG is 217% higher.
CME has a PEG ratio above that of peer stocks ICE and NDAQ. At 1.52, CME Group Inc - Class A's PEG ratio stands higher than the peer group average of 0.85.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| CBOE Cboe Global Markets Inc | 0.46 | $31.1B |
| ICE Intercontinental Exchange Inc | 0.6 | $85.22B |
| NDAQ Nasdaq Inc - 144A | 0.85 | $52.62B |
| MSCI MSCI Inc | 1.48 | $41.76B |
| CME CME Group Inc - Class A | 1.51 | $95.71B |
CME shows a PEG ratio of 1.52, per Jul 31, 2026 data.
CME's 3-year PEG ratio average stands at 1.88.
CME's 5-year PEG ratio average stands at 3.35.
The Dec 2022 quarter marked the ten years high at 15.13 for CME's PEG ratio.
Currently, CME's PEG ratio stands 50% lower than its 10-year historical average.
To calculate the PEG ratio, take the company's PE ratio and divide by its EPS growth (YoY TTM). As of Jul 31, 2026, CME Group Inc - Class A has a P/E ratio of 22.54. Earnings grew at 14.8% over the TTM period ending Jun 2026. Applying the formula, this produces a price to earnings growth ratio of 1.52. PEG RATIO(1.52) = PE RATIO(22.54) / EPS GROWTH(14.8%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.